A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies.

MLA

Huang, Anfei, et al. “A Human Programmed Death-Ligand 1-Expressing Mouse Tumor Model for Evaluating the Therapeutic Efficacy of Anti-Human PD-L1 Antibodies.” Scientific Reports, vol. 7, Feb. 2017, p. 42687. EBSCOhost, https://doi.org/10.1038/srep42687.

APA

Huang, A., Peng, D., Guo, H., Ben, Y., Zuo, X., Wu, F., Yang, X., Teng, F., Li, Z., Qian, X., & Qin, F. X.-F. (2017). A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies. Scientific Reports, 7, 42687. https://doi.org/10.1038/srep42687

Chicago

Huang, Anfei, Di Peng, Huanhuan Guo, Yinyin Ben, Xiangyang Zuo, Fei Wu, Xiaoli Yang, et al. 2017. “A Human Programmed Death-Ligand 1-Expressing Mouse Tumor Model for Evaluating the Therapeutic Efficacy of Anti-Human PD-L1 Antibodies.” Scientific Reports 7 (February): 42687. doi:10.1038/srep42687.